The Swansea Baby Study
Probiotics in the prevention of eczema: a randomized controlled trial
This large randomised, double blind, placebo controlled study was designed to evaluate whether Lab4b probiotics given during infancy could prevent allergy in children.
Atopic eczema – Infants (%)
Atopic sensitization – Skin prick testing positive (%)
The primary author, Prof. Steve Allen, concluded the following key message from the trial: ‘Lactobacilli and Bifidobacteria administered to pregnant women and infants aged 0-6 months prevented atopic sensitization and atopic eczema.’